These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 23474685)

  • 1. Regulation of human papillomavirus gene expression by splicing and polyadenylation.
    Johansson C; Schwartz S
    Nat Rev Microbiol; 2013 Apr; 11(4):239-51. PubMed ID: 23474685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splicing and Polyadenylation of Human Papillomavirus Type 16 mRNAs.
    Wu C; Kajitani N; Schwartz S
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Viral Ribonucleoproteins in Human Papillomavirus Type 16 Gene Expression.
    Kajitani N; Schwartz S
    Viruses; 2020 Sep; 12(10):. PubMed ID: 33007936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the DNA Damage Response in Human Papillomavirus RNA Splicing and Polyadenylation.
    Nilsson K; Wu C; Schwartz S
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA splicing factors regulated by HPV16 during cervical tumour progression.
    Mole S; McFarlane M; Chuen-Im T; Milligan SG; Millan D; Graham SV
    J Pathol; 2009 Nov; 219(3):383-91. PubMed ID: 19718710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratinocyte Differentiation-Dependent Human Papillomavirus Gene Regulation.
    Graham SV
    Viruses; 2017 Aug; 9(9):. PubMed ID: 28867768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation.
    Tang S; Tao M; McCoy JP; Zheng ZM
    J Virol; 2006 May; 80(9):4249-63. PubMed ID: 16611884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation.
    Yu L; Majerciak V; Zheng ZM
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome.
    Cheung JL; Cheung TH; Yu MY; Chan PK
    Gynecol Oncol; 2013 Nov; 131(2):374-9. PubMed ID: 24012799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing.
    Dhanjal S; Kajitani N; Glahder J; Mossberg AK; Johansson C; Schwartz S
    J Biol Chem; 2015 May; 290(21):13354-71. PubMed ID: 25878250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research progress in roles of high-risk human papillomavirus E2 protein].
    Wu EQ; Tang YY
    Bing Du Xue Bao; 2014 Mar; 30(2):201-7. PubMed ID: 24923176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms and functional analysis of the intact human papillomavirus16 e2 gene.
    Ekalaksananan T; Jungpol W; Prasitthimay C; Wongjampa W; Kongyingyoes B; Pientong C
    Asian Pac J Cancer Prev; 2014; 15(23):10255-62. PubMed ID: 25556457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of human papillomavirus gene expression by alternative splicing.
    Graham SV; Faizo AAA
    Virus Res; 2017 Mar; 231():83-95. PubMed ID: 27867028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
    Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
    Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
    Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
    Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression.
    Rush M; Zhao X; Schwartz S
    J Virol; 2005 Sep; 79(18):12002-15. PubMed ID: 16140776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Star-PAP controls HPV E6 regulation of p53 and sensitizes cells to VP-16.
    Li W; Anderson RA
    Oncogene; 2014 Feb; 33(7):928-32. PubMed ID: 23416977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HPV-16 E5 protein represses expression of stress pathway genes XBP-1 and COX-2 in genital keratinocytes.
    Sudarshan SR; Schlegel R; Liu X
    Biochem Biophys Res Commun; 2010 Sep; 399(4):617-22. PubMed ID: 20688044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
    Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
    Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.